Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients.

MLA

Virseda, Berdices, Ana, et al. “Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients.” Liver International, vol. 45, no. 1, Jan. 2025, pp. 1–7. EBSCOhost, https://doi.org/10.1111/liv.16204.

APA

Virseda, B. A., Martín, E. R., Berenguer, J., González, G. J., Brochado, K. O., Rojo, D., Díez, C., Hontañon, V., Pérez, L. L., Ibañez, S. L., Llop, H. E., Olveira, A., Fernández, R. A., Barbas, C., Resino, S., Jiménez, S. M. Á., Ibáñez, L., Rincón, D., Aldámiz, E. T., & Catalina, V. (2025). Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients. Liver International, 45(1), 1–7. https://doi.org/10.1111/liv.16204

Chicago

Virseda, Berdices, Ana, Escolano, Rubén Martín, Juan Berenguer, García, Juan González, Kith, Oscar Brochado, David Rojo, Cristina Díez, et al. 2025. “Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients.” Liver International 45 (1): 1–7. doi:10.1111/liv.16204.